Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Facchetti, F.
357  Ergebnisse:
Personensuche X
?
1

Bulevirtide monotherapy prevents liver decompensation and r..:

Degasperi, E. ; De Silvestri, A. ; Anolli, M.P....
Digestive and Liver Disease.  56 (2024)  - p. S31-S32 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Kinetics of the three HBsAg forms along with HDV-RNA predic..:

D'Anna, S. ; Salpini, R. ; Degasperi, E....
Digestive and Liver Disease.  56 (2024)  - p. S32 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Quantification of plasma HDV RNA in untreated and Bulevirti..:

Anolli, M.P. ; Renteria, S. Uceda ; Degasperi, E....
Digestive and Liver Disease.  56 (2024)  - p. S33 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Improvement of non-invasive fibrosis tests in HDV cirrhotic..:

Degasperi, E. ; Anolli, M.P. ; Renteria, S. Uceda...
Digestive and Liver Disease.  56 (2024)  - p. S34 , 2024
Link: https://doi.org/10.1016/..
 
?
5

OC.18.5: ASAP SCORE MAY PREDICT HCC RECURRENCE AFTER COMPLE..:

Canova, L. ; Iavarone, M. ; Alimenti, E....
Digestive and Liver Disease.  56 (2024)  - p. S216-S217 , 2024
Link: https://doi.org/10.1016/..
 
?
6

BOC.01.3: LONG-TERM HIGH-RISK OF DE-NOVO HBV-HEPATITIS (DNH..:

Dondossola, D. ; Loglio, A. ; Viganò, M....
Digestive and Liver Disease.  56 (2024)  - p. S102-S103 , 2024
Link: https://doi.org/10.1016/..
 
?
7

ASAP score may predict HCC recurrence after complete radiol..:

Canova, L. ; Iavarone, M. ; Alimenti, E....
Digestive and Liver Disease.  56 (2024)  - p. S89 , 2024
Link: https://doi.org/10.1016/..
 
?
8

MYC ALTERATIONS IN HIV‐ASSOCIATED B CELL LYMPHOMAS: RESULTS..:

Pagani, C. ; Rusconi, C. ; Pria, A. Dalla...
Hematological Oncology.  41 (2023)  S2 - p. 653-654 , 2023
Link: https://doi.org/10.1002/..
 
?
9

Improvement of clinical parameters in HDV patients with adv..:

Degasperi, E. ; Anolli, M.P. ; Renteria, S.C. Uceda...
Digestive and Liver Disease.  55 (2023)  - p. S29 , 2023
Link: https://doi.org/10.1016/..
 
?
10

Divergent patterns of hbv-rna and hbcrag levels in untreate..:

Degasperi, E. ; Loglio, A. ; Scholtes, C....
Digestive and Liver Disease.  54 (2022)  - p. S38-S39 , 2022
Link: https://doi.org/10.1016/..
 
?
11

Humoral, cellular, clinical responses and safety of two dos..:

Iavarone, M. ; Tosetti, G. ; Facchetti, F....
Digestive and Liver Disease.  54 (2022)  - p. S1 , 2022
Link: https://doi.org/10.1016/..
 
?
12

Comparative performance analysis between manual and automat..:

Degasperi, E. ; Renteria, S.C. Uceda ; Loglio, A....
Digestive and Liver Disease.  54 (2022)  - p. S39-S40 , 2022
Link: https://doi.org/10.1016/..
 
?
13

Diabetes and number of metabolic risk factors influence liv..:

D'Ambrosio, R. ; Perbellini, R. ; Fugazza, F....
Digestive and Liver Disease.  54 (2022)  - p. S35-S36 , 2022
Link: https://doi.org/10.1016/..
 
?
14

Switching tdf treated patients to taf is a safe and effecti..:

Degasperi, E. ; Loglio, A. ; Viganò, M....
Digestive and Liver Disease.  54 (2022)  - p. S36 , 2022
Link: https://doi.org/10.1016/..
 
?
15

Effectiveness and safety of bulevirtide monotherapy 2 mg/di..:

Degasperi, E. ; Loglio, A. ; Uceda Renteria, S.C....
Digestive and Liver Disease.  54 (2022)  - p. S15 , 2022
Link: https://doi.org/10.1016/..
 
1-15